(Stroke. 1999;30:638-643.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Correspondence to Dr A.P. Davenport, Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. E-mail apd10{at}medschl.cam.ac.uk
Background and PurposeSubstantial evidence now implicates endothelin (ET) in the pathophysiology of cerebrovascular disorders such as the delayed vasospasm associated with subarachnoid hemorrhage and ischemic stroke. We investigated the ET receptor subtypes mediating vasoconstriction in human pial arteries.
MethodsET receptors on human pial and intracerebral arteries were visualized with the use of autoradiography, and the subtypes mediating vasoconstriction were identified by means of wire myography.
ResultsET-1 was more potent than ET-3 as a vasoconstrictor, indicating an ETA-mediated effect. Similarly, the selective ETB agonist sarafotoxin S6c had no effect on contractile action at concentrations up to 30 nmol/L. The nonpeptide ETA receptor antagonist PD156707 (3 to 30 nmol/L) caused a parallel rightward shift of the ET-1induced response, yielding a pA2 of 9.2. Consistent with these results, PD156707 (30 nmol/L) fully reversed an established constriction in pial arteries induced by 1 nmol/L ET-1, while the selective ETB receptor antagonist BQ788 (1 µmol/L) had little effect. The calcium channel blocker nimodipine (0.3 to 3 µmol/L) significantly attenuated the maximum response to ET-1 in a concentration-dependent manner without changing potency. In agreement with the functional data, specific binding of [125I]PD151242 to ETA receptors was localized to the smooth muscle layer of pial and intracerebral blood vessels. In contrast, little or no [125I]BQ3020 binding to ETB receptors was detected.
ConclusionsThese data indicate an important role for ETA receptors in ET-1induced constriction of human pial arteries and suggest that ETA receptor antagonists may provide additional dilatory benefit in cerebrovascular disorders associated with raised ET levels.
Anesthesia Research, Mayo Clinic, Rochester, Minnesota
This article has been cited by other articles:
![]() |
G. Michelson, S. Warntges, S. Leidig, J. Lotsch, and G. Geisslinger Nimodipine plasma concentration and retinal blood flow in healthy subjects. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3479 - 3486. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Andresen, N. I. Shafi, and R. M. Bryan Jr. Endothelial influences on cerebrovascular tone J Appl Physiol, January 1, 2006; 100(1): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chuquet, K. Benchenane, J. Toutain, E. T. MacKenzie, S. Roussel, and O. Touzani Selective Blockade of Endothelin-B Receptors Exacerbates Ischemic Brain Damage in the Rat Stroke, December 1, 2002; 33(12): 3019 - 3025. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Flemming, A Cheong, A M Dedman, and D J Beech Discrete store-operated calcium influx into an intracellular compartment in rabbit arteriolar smooth muscle J. Physiol., September 1, 2002; 543(2): 455 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Docherty, J. Kalmar-Nagy, M. Engelen, S. V. Koenen, M. Nijland, R. E. Kuc, A. P. Davenport, and P. W. Nathanielsz Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1 Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R261 - R268. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |